1021 — Southampton, New York

1021 is a clinical research site located in Southampton, New York, United States 11968.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

1021 has participated in 1 clinical trials.

Therapeutic areas: Paroxysmal Supraventricular Tachycardia.

Sponsors: Milestone Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 1021?

1021 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 1021 conducted?

1021 has 1 clinical trials on record. Their work covers Paroxysmal Supraventricular Tachycardia.

Is 1021 accredited by Crixeo Health?

1021 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 1021?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.